Meropenem Aptapharma (Meropenem Trihydrate)

Meropenem, the active ingredient in Meropenem Aptapharma, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, septicemia and meningitis in hospitalized patients.

GNH USA supplies Meropenem Aptapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens. - Complicated urinary tract infections: eradicates resistant Gram‑negative and Gram‑positive organisms. - Nosocomial pneumonia: treats hospital‑acquired lung infections caused by multidrug‑resistant bacteria. - Septicemia: rapidly clears bloodstream infections with susceptible organisms. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: may be watery or loose. - Rash: skin redness or itching. - Headache: transient cranial discomfort. - Elevated liver enzymes: mild hepatic enzyme rise. - Injection site reaction: pain or erythema at the infusion site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or high doses. - Anaphylaxis: severe allergic reaction with airway compromise. - Clostridioides difficile‑associated diarrhea: potential for severe colitis. - Severe neutropenia: marked reduction in white blood cells. - Renal dysfunction: worsening kidney function. - Stevens‑Johnson syndrome: rare mucocutaneous blistering disorder.

Meropenem should be used with caution in specific clinical situations.

- Renal function: adjust dose in patients with impaired renal clearance. - Allergy history: avoid in individuals with known hypersensitivity to carbapenems or other β‑lactams. - Seizure risk: monitor patients with central nervous system disorders or receiving high doses. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk; safety data are limited. - Antibiotic stewardship: restrict use to confirmed bacterial infections to limit resistance development. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several drugs, requiring careful management.

Major Interactions (Avoid): - Valproic acid: concurrent use can lower valproate levels and precipitate seizures. - Probenecid: may increase meropenem plasma concentrations, raising toxicity risk. - Other nephrotoxic agents: combined use may exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: increased risk of nephrotoxicity when used together. - Anticoagulants (e.g., warfarin): infection may affect INR; monitor coagulation parameters.